hrcak mascot   Srce   HID

Stručni rad

CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer

Milena Gnjidić
Željko Vojnović
Mislav Čonkaš
Filip Grubišić Čabo
Borislav Belev
Anuška Budisavljević
Ivan Gilja
Natalija Dedić Plavetić
Robert Šeparović

Puni tekst: hrvatski, pdf (798 KB) str. 0-0 preuzimanja: 515* citiraj
APA 6th Edition
Gnjidić, M., Vojnović, Ž., Čonkaš, M., Grubišić Čabo, F., Belev, B., Budisavljević, A., ... Šeparović, R. (2016). PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa. Liječnički vjesnik, 138 (7-8), 0-0. Preuzeto s https://hrcak.srce.hr/172865
MLA 8th Edition
Gnjidić, Milena, et al. "PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa." Liječnički vjesnik, vol. 138, br. 7-8, 2016, str. 0-0. https://hrcak.srce.hr/172865. Citirano 24.10.2019.
Chicago 17th Edition
Gnjidić, Milena, Željko Vojnović, Mislav Čonkaš, Filip Grubišić Čabo, Borislav Belev, Anuška Budisavljević, Ivan Gilja, Natalija Dedić Plavetić i Robert Šeparović. "PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa." Liječnički vjesnik 138, br. 7-8 (2016): 0-0. https://hrcak.srce.hr/172865
Harvard
Gnjidić, M., et al. (2016). 'PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa', Liječnički vjesnik, 138(7-8), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172865 (Datum pristupa: 24.10.2019.)
Vancouver
Gnjidić M, Vojnović Ž, Čonkaš M, Grubišić Čabo F, Belev B, Budisavljević A i sur. PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa. Liječnički vjesnik [Internet]. 2016 [pristupljeno 24.10.2019.];138(7-8):0-0. Dostupno na: https://hrcak.srce.hr/172865
IEEE
M. Gnjidić, et al., "PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa", Liječnički vjesnik, vol.138, br. 7-8, str. 0-0, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/172865. [Citirano: 24.10.2019.]

Sažetak
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the follow–up of ­oncological patients after primary treatment, in patients with renal cell cancer, urinary bladder cancer, prostate cancer and testicular cancer.

Ključne riječi
Kidney neoplasms – diagnosis, pathology, therapy; Carcinoma, renal cell – diagnosis, pathology, therapy; Urinary bladder neoplasms – diagnosis, pathology, therapy; Prostatic neoplasms – diagnosis, pathology, therapy; Testicular neoplasms – diagnosis, pathology, therapy; Seminoma – diagnosis, pathology, therapy; Neoplasm staging; Medical oncology – standards; Practice guidelines as topic – standards; Follow-up studies; Croatia

Hrčak ID: 172865

URI
https://hrcak.srce.hr/172865

[hrvatski]

Posjeta: 713 *